BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 9218758)

  • 21. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
    Kalina U; Koschmieder S; Hofmann WK; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
    Exp Hematol; 2001 May; 29(5):602-8. PubMed ID: 11376873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
    Demoulin JB; Uyttenhove C; Lejeune D; Mui A; Groner B; Renauld JC
    Cancer Res; 2000 Jul; 60(14):3971-7. PubMed ID: 10919676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
    Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
    J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F; Chiarenza A; Goffin V; Kelly PA
    Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.
    Liu J; Kern JA
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):306-13. PubMed ID: 12204892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.
    Migone TS; Lin JX; Cereseto A; Mulloy JC; O'Shea JJ; Franchini G; Leonard WJ
    Science; 1995 Jul; 269(5220):79-81. PubMed ID: 7604283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells.
    Kamiya S; Owaki T; Morishima N; Fukai F; Mizuguchi J; Yoshimoto T
    J Immunol; 2004 Sep; 173(6):3871-7. PubMed ID: 15356135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases.
    Sengupta TK; Talbot ES; Scherle PA; Ivashkiv LB
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11107-12. PubMed ID: 9736697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-beta1 is mediated by caspase-dependent and -independent processes.
    Wierenga AT; Schuringa JJ; Eggen BJ; Kruijer W; Vellenga E
    Leukemia; 2002 Apr; 16(4):675-82. PubMed ID: 11960349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
    Kirken RA; Rui H; Malabarba MG; Howard OM; Kawamura M; O'Shea JJ; Farrar WL
    Cytokine; 1995 Oct; 7(7):689-700. PubMed ID: 8580378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of interleukin-2 unresponsiveness and down-regulation of the JAK-STAT system upon activation through the T cell receptor.
    Miyatake S; Sakuma M; Saito T
    Eur J Immunol; 1997 Jul; 27(7):1816-23. PubMed ID: 9247597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
    Cheng J; Zhang D; Zhou C; Marasco WA
    Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
    Bellido T; Borba VZ; Roberson P; Manolagas SC
    Endocrinology; 1997 Sep; 138(9):3666-76. PubMed ID: 9275051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
    Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
    J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells.
    Foxwell BM; Beadling C; Guschin D; Kerr I; Cantrell D
    Eur J Immunol; 1995 Nov; 25(11):3041-6. PubMed ID: 7489741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
    Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
    Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit interleukin-2-induced Jak/STAT signalling in human CD4 T lymphocytes.
    Kryworuchko M; Pasquier V; Thèze J
    Clin Exp Immunol; 2003 Mar; 131(3):422-7. PubMed ID: 12605694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-β by CD4+ T cells.
    Cetkovic-Cvrlje M; Olson M; Ghate K
    Cell Mol Immunol; 2012 Jul; 9(4):350-60. PubMed ID: 22728763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.